Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4.
暂无分享，去创建一个
M. Noble | J. Endicott | S. Cook | I. Hardcastle | S. Wedge | R. Griffin | B. Golding | D. Newell | P. Lochhead | Lan Z. Wang | J. Tucker | Mathew P. Martin | H. Thomas | Duncan C Miller | C. Cano | Tristan Reuillon | L. Rigoreau | T. Hammonds | Leon Pang | S. Harnor | A. Wong | Stephanie M. Myers | Lauren Molyneux | Mercedes Arasta | Ruth H. Bawn | T. Blackburn | N. Edwards | Amy B Heptinstall | N. Martin | P. Owen | Mathew P Martin | Ian R. Hardcastle | Ruth H. Bawn | Suzannah J. Harnor | Céline Cano | Amy B. Heptinstall